NASDAQ
APLM
Last Price
US $15.70
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Apollomics, Inc. cash flow to debt ratio of -1.61K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Apollomics, Inc.'s free cash flow has increased -63.96% from $-28.77M last year to $-10.37M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Apollomics, Inc.'s debt to equity ratio is -0.20, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Healthy debt to equity ratio development.
Apollomics, Inc.'s debt to equity ratio is -0.20, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Net debt/EBITDA.
Apollomics, Inc. has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Apollomics, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Financial stability - Profit margin growth.
Apollomics, Inc.'s profit margin has increased (-99.53%) in the last year from -27.20K% to -128.69%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
Apollomics, Inc.'s short-term liabilities of $6.33M exceed its short-term assets of $6.05M, signaling financial risk
Decreasing performance - ROA.
Apollomics, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Increasing performance - Absolute return on equity.
Apollomics, Inc.'s return on equity of 288.40%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
Apollomics, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Apollomics, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Apollomics, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Apollomics, Inc. has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Apollomics, Inc.'s yearly earnings has increased -79.69% since last year from $-53.86M to $-10.94M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Apollomics, Inc.'s yearly revenue has increased 4.19K% since last year from $198.00K to $8.50M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -1.59K% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Apollomics, Inc.'s 3-year revenue CAGR of 197.44% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Apollomics, Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Apollomics, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Apollomics, Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Apollomics, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Apollomics, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Apollomics, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Apollomics, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Apollomics, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
Apollomics, Inc. has a price-to-sales ratio of 0.78x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
288.40%
Return on equity
ROIC: -1586.77%
Valuation History
-2.5X
Price to Earnings
EV/EBITDA: -1.9X
Cash flow
Profit margin
34.46%
(FY vs FY)
Cash flow Y/Y
28.14%
(FY vs FY)
Fair Value
Market $15.70
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.